OR WAIT null SECS
© 2022 MJH Life Sciences and Consultant Live. All rights reserved.
December 03, 2021
Expert clinicians discuss insulin therapy for treating type 2 diabetes and comment on what to look forward to in the future of diabetes care.
Drs Dennis Bruemmer and Jennifer Green review recent trial data on a novel combination of GIP and GLP1 receptor agonists to treat type 2 diabetes.
November 26, 2021
Thought leaders discuss recent advances in treatments for patients with type 2 diabetes with chronic kidney disease.
Dennis Bruemmer, MD, PhD, and Jennifer B. Green, MD, have a conversation about the use of SGLT2 inhibitors and GLP1 receptor agonists in treating type 2 diabetes.